OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers

(2010) D C Buse et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain

(2008) Danièle Ranoux et al.   ANNALS OF NEUROLOGY

Guidelines for Controlled Trials of Prophylactic Treatment of Chronic Migraine in Adults

(2008) S Silberstein et al.   CEPHALALGIA

The Importance of Placebo in Headache Research

(2008) H-C Diener et al.   CEPHALALGIA

Clinical Comparisons of Botulinum Neurotoxin Formulations

(2008) Allison Brashear   NEUROLOGIST

Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment

(2008) M. E. Bigal et al.   NEUROLOGY

Botulinum neurotoxins in the treatment of refractory pain

(2008) Bahman Jabbari   Nature clinical practice. Neurology